['RIFABUTIN, PHENYTOIN, EFAVIRENZ, CIMETIDINE, ESOMEPRAZOLE', 'AVOID COADMINISTRATION UNLESS THE BENEFIT OUTWEIGHS THE RISKS ( 7.6 , 7.7 , 7.8 , 7.9 )', 'OTHER DRUGS METABOLIZED BY CYP3A4 (TACROLIMUS, CYCLOSPORINE, VINCA ALKALOIDS, CALCIUM CHANNEL BLOCKERS)', 'CONSIDER DOSAGE ADJUSTMENT AND MONITOR FOR ADVERSE EFFECTS AND TOXICITY ( 7.1 , 7.10 , 7.11 )', 'DIGOXIN', 'MONITOR DIGOXIN PLASMA CONCENTRATIONS ( 7.12 )', 'FOSAMPRENAVIR, METOCLOPRAMIDE', 'MONITOR FOR BREAKTHROUGH FUNGAL INFECTIONS ( 7.6 , 7.13 )']